Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023

This new post hoc analysis of the Phase 3 EMERALD trial evaluated elacestrant…

HH Global discloses environmental impact through CDP

LONDON, Dec. 8, 2023 /PRNewswire/ — HH Global has furthered its commitment…

Focusing on the "Belt and Road", 2023 "SHOW JIANGSU" Photography Project Successfully Concluded

NANJING, China, Dec. 8, 2023 /PRNewswire/ — On November 13, the "Belt…

2023 World Automotive Chip Innovation Conference Held in Binhu, Wuxi

WUXI, China, Dec. 8, 2023 /PRNewswire/ — From December 5th to 6th,…

The 2023 Global Investment Promotion Conference Held in Shenzhen, China

SHENZHEN, China, Dec. 8, 2023 /PRNewswire/ — On December 8, the 2023 Shenzhen…

Courtyard by Marriott Bali Nusa Dua Resort Elevates Guests' Experience through Exciting Family-Friendly Facilities and Activities

BALI, Indonesia, Dec. 8, 2023 /PRNewswire/ — Courtyard by Marriott Bali Nusa…

TCL CSOT Redefines the Future of Display at Global Display Tech-ecosystem Conference 2023

SHENZHEN, China, Dec. 8, 2023 /PRNewswire/ — TCL CSOT, a renowned industry…